Artal Group as of June 30, 2018
Portfolio Holdings for Artal Group
Artal Group holds 94 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Weight Watchers International | 44.7 | $2.1B | 21M | 101.10 | |
| Lexicon Pharmaceuticals (LXRX) | 15.4 | $723M | 60M | 12.00 | |
| Bank of America Corporation (BAC) | 3.8 | $179M | 6.4M | 28.19 | |
| Celgene Corporation | 3.4 | $159M | 2.0M | 79.42 | |
| Beigene (BGNE) | 2.2 | $104M | 675k | 153.73 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $74M | 750k | 98.49 | |
| Morgan Stanley (MS) | 1.5 | $71M | 1.5M | 47.40 | |
| Bristol Myers Squibb (BMY) | 1.5 | $69M | 1.3M | 55.34 | |
| Goldman Sachs (GS) | 1.4 | $66M | 300k | 220.57 | |
| General Motors Company (GM) | 1.3 | $59M | 1.5M | 39.40 | |
| Nektar Therapeutics (NKTR) | 1.2 | $59M | 1.2M | 48.83 | |
| Blueprint Medicines (BPMC) | 1.2 | $57M | 900k | 63.48 | |
| Wells Fargo & Company (WFC) | 1.2 | $55M | 1.0M | 55.44 | |
| Amicus Therapeutics (FOLD) | 1.1 | $53M | 3.4M | 15.62 | |
| Acceleron Pharma | 1.1 | $53M | 1.1M | 48.52 | |
| Tesaro | 1.1 | $51M | 1.2M | 44.47 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.1 | $49M | 450k | 109.82 | |
| Medicines Company | 0.9 | $40M | 1.1M | 36.70 | |
| Scholar Rock Hldg Corp (SRRK) | 0.8 | $37M | 2.4M | 15.60 | |
| Atara Biotherapeutics (ATRA) | 0.8 | $37M | 1.0M | 36.75 | |
| Bluebird Bio (BLUE) | 0.7 | $35M | 220k | 156.95 | |
| Agios Pharmaceuticals (AGIO) | 0.7 | $34M | 400k | 84.23 | |
| Array BioPharma | 0.7 | $34M | 2.0M | 16.78 | |
| Accelr8 Technology | 0.5 | $22M | 1.0M | 22.30 | |
| Zogenix | 0.5 | $22M | 500k | 44.20 | |
| Fate Therapeutics (FATE) | 0.4 | $19M | 1.7M | 11.34 | |
| BioMarin Pharmaceutical (BMRN) | 0.4 | $19M | 200k | 94.20 | |
| Albireo Pharma | 0.4 | $18M | 500k | 35.50 | |
| Freeport-McMoRan Copper & Gold (FCX) | 0.4 | $17M | 1.0M | 17.26 | |
| Inflarx Nv (IFRX) | 0.3 | $16M | 500k | 32.25 | |
| Sage Therapeutics (SAGE) | 0.3 | $16M | 100k | 156.53 | |
| Fibrogen (FGEN) | 0.3 | $16M | 250k | 62.60 | |
| Xencor (XNCR) | 0.3 | $15M | 400k | 37.01 | |
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $14M | 50k | 279.70 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $14M | 200k | 71.04 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.3 | $14M | 525k | 26.79 | |
| Zafgen | 0.3 | $12M | 1.2M | 10.23 | |
| Argenx Se (ARGX) | 0.3 | $12M | 150k | 82.86 | |
| Exelixis (EXEL) | 0.2 | $11M | 500k | 21.52 | |
| Cymabay Therapeutics | 0.2 | $11M | 800k | 13.42 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $11M | 1.5M | 7.30 | |
| Regenxbio Inc equity us cm (RGNX) | 0.2 | $11M | 150k | 71.75 | |
| Global Blood Therapeutics In | 0.2 | $9.0M | 200k | 45.20 | |
| Audentes Therapeutics | 0.2 | $9.0M | 236k | 38.21 | |
| Iovance Biotherapeutics (IOVA) | 0.2 | $9.0M | 700k | 12.80 | |
| Solid Biosciences | 0.2 | $8.9M | 250k | 35.63 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $7.9M | 400k | 19.63 | |
| Denali Therapeutics (DNLI) | 0.2 | $7.6M | 500k | 15.25 | |
| La Jolla Pharmaceuticl Com Par | 0.1 | $7.3M | 250k | 29.17 | |
| Vital Therapies | 0.1 | $6.9M | 1.0M | 6.85 | |
| D Stemline Therapeutics | 0.1 | $6.4M | 400k | 16.05 | |
| Selecta Biosciences (RNAC) | 0.1 | $6.6M | 500k | 13.25 | |
| Aerpio Pharmaceuticals | 0.1 | $6.5M | 1.6M | 4.15 | |
| Agenus (AGEN) | 0.1 | $6.2M | 2.8M | 2.27 | |
| Translate Bio | 0.1 | $6.3M | 500k | 12.65 | |
| Ac Immune Sa (ACIU) | 0.1 | $5.6M | 600k | 9.32 | |
| Tg Therapeutics (TGTX) | 0.1 | $5.3M | 400k | 13.15 | |
| Dicerna Pharmaceuticals | 0.1 | $5.2M | 425k | 12.25 | |
| Spero Therapeutics (SPRO) | 0.1 | $5.1M | 350k | 14.67 | |
| Restorbio | 0.1 | $5.0M | 550k | 9.15 | |
| Clovis Oncology | 0.1 | $4.5M | 100k | 45.47 | |
| Akebia Therapeutics (AKBA) | 0.1 | $4.7M | 475k | 9.98 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $4.1M | 217k | 19.12 | |
| Glycomimetics (GLYC) | 0.1 | $4.0M | 250k | 16.13 | |
| Idera Pharmaceuticals | 0.1 | $3.6M | 2.8M | 1.32 | |
| Marinus Pharmaceuticals | 0.1 | $3.5M | 500k | 7.07 | |
| Dynavax Technologies (DVAX) | 0.1 | $3.8M | 250k | 15.25 | |
| Aduro Biotech | 0.1 | $3.9M | 550k | 7.00 | |
| Wave Life Sciences (WVE) | 0.1 | $3.8M | 100k | 38.25 | |
| Synlogic | 0.1 | $3.9M | 400k | 9.83 | |
| Arcus Biosciences Incorporated (RCUS) | 0.1 | $3.7M | 300k | 12.24 | |
| Avrobio Ord (AVRO) | 0.1 | $3.6M | 125k | 28.56 | |
| Miragen Therapeutics | 0.1 | $3.2M | 500k | 6.41 | |
| Sangamo Biosciences (SGMO) | 0.1 | $2.8M | 200k | 14.20 | |
| Crispr Therapeutics (CRSP) | 0.1 | $2.9M | 50k | 58.76 | |
| Clementia | 0.1 | $2.6M | 200k | 13.16 | |
| Unity Biotechnology | 0.1 | $3.0M | 200k | 15.06 | |
| Tricida | 0.1 | $3.0M | 100k | 29.90 | |
| Magenta Therapeutics | 0.1 | $2.7M | 200k | 13.50 | |
| Chimerix (CMRX) | 0.1 | $2.4M | 500k | 4.76 | |
| Adverum Biotechnologies | 0.1 | $2.1M | 400k | 5.30 | |
| Intellia Therapeutics (NTLA) | 0.1 | $2.5M | 90k | 27.36 | |
| Krystal Biotech (KRYS) | 0.1 | $2.2M | 150k | 14.87 | |
| Homology Medicines | 0.0 | $2.0M | 100k | 20.40 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.0 | $1.7M | 100k | 17.35 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $1.4M | 150k | 9.20 | |
| Sienna Biopharmaceuticals (SNNAQ) | 0.0 | $1.5M | 99k | 15.19 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $900k | 150k | 6.00 | |
| Noveliontherapeuti.. | 0.0 | $944k | 256k | 3.68 | |
| Tocagen | 0.0 | $934k | 100k | 9.34 | |
| Novavax | 0.0 | $670k | 500k | 1.34 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.0 | $455k | 500k | 0.91 | |
| Oncocyte | 0.0 | $383k | 150k | 2.55 | |
| Syndax Pharmaceuticals (SNDX) | 0.0 | $426k | 61k | 7.02 |
